The following information is missing from the Funding section: This work was supported by the National Institute of Allergy and Infectious Diseases (grant no. HHSN272200800056C to BC).
Reference
- 1. Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, et al. (2018) A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLoS ONE 13(2): e0192312. https://doi.org/10.1371/journal.pone.0192312 pmid:29462200
Citation: Callendret B, Vellinga J, Wunderlich K, Rodriguez A, Steigerwald R, Dirmeier U, et al. (2018) Correction: A prophylactic multivalent vaccine against different filovirus species is immunogenic and provides protection from lethal infections with Ebolavirus and Marburgvirus species in non-human primates. PLoS ONE 13(4): e0196546. https://doi.org/10.1371/journal.pone.0196546
Published: April 24, 2018
Copyright: © 2018 Callendret et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.